169 related articles for article (PubMed ID: 16575580)
1. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.
Lee JH; Choi SJ; Lee JH; Park JH; Kim H; Joo YD; Lee WS; Zang DY; Kim HJ; Lee KH;
Ann Hematol; 2006 Jun; 85(6):357-65. PubMed ID: 16575580
[TBL] [Abstract][Full Text] [Related]
2. [Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols].
del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Krsnik I; Guerra JL; Llorente L; López JC; Díaz Morfa M; Villegas A
Med Clin (Barc); 1989 Apr; 92(16):601-4. PubMed ID: 2747321
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute myelogenous leukemia in the elderly.
Champlin RE; Gajewski JL; Golde DW
Semin Oncol; 1989 Feb; 16(1):51-6. PubMed ID: 2645650
[TBL] [Abstract][Full Text] [Related]
4. [Differentiation induction of myeloid leukemia cells by glucocorticoid--the differentiation induction effect in vitro and in vivo].
Nakamaki T; Sakashita A; Sano M; Hino K; Suzuki K; Tomoyasu S; Tsuruoka N
Rinsho Ketsueki; 1989 Feb; 30(2):149-57. PubMed ID: 2746870
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute non-lymphoid leukemias: comparison of two protocols.
Hauptmann E; Stacher A; Heinz R; Jaksic B
Osterr Z Onkol; 1977 Dec; 4(4):80-2. PubMed ID: 271937
[TBL] [Abstract][Full Text] [Related]
6. Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents.
Fagioli F; Cuneo A; Piva N; Carli MG; Previati R; Balboni M; Tomasi P; Cariani D; Scapoli G; Castoldi G
Cancer; 1992 Jul; 70(1):77-85. PubMed ID: 1606550
[TBL] [Abstract][Full Text] [Related]
7. [Factors related to prognosis and relapse in acute myelomonocytic and monocytic leukemias (M4 and M5)].
Koyama A; Shirakawa C; Masaki H; Horiuchi F; Hamazaki H; Fujimoto T; Irimajiri K; Horiuchi A
Rinsho Ketsueki; 1990 Nov; 31(11):1787-93. PubMed ID: 2287062
[TBL] [Abstract][Full Text] [Related]
8. [Results of treatment of acute luekemia in adults according to our records].
Kotlarek-Haus S; Witkowska M; Kuliszkiewicz M
Acta Haematol Pol; 1975; 6(1):51-8. PubMed ID: 1054903
[TBL] [Abstract][Full Text] [Related]
9. Overshoot phenomenon of phytohemagglutinin response after chemotherapy and its relationship to remission in acute non-lymphocytic leukemia.
Harada M; Mori T; Kodo H; Ishino C; Matsue K; Hattori K
Gan; 1979 Feb; 70(1):89-93. PubMed ID: 286667
[TBL] [Abstract][Full Text] [Related]
10. Curative effect of harringtonine semisynthetic harringtonine and HOAP on nonlymphocytic leukemias. Analysis of 304 cases.
Zhang ZY; Hou CH; Zhu YF; You XY; Li JL; Fu Z
Chin Med J (Engl); 1987 Jul; 100(7):565-8. PubMed ID: 3123163
[No Abstract] [Full Text] [Related]
11. Uncommon subtypes of acute nonlymphocytic leukemia: clinical features and management of FAB M5, M6 and M7.
Peterson BA; Levine EG
Semin Oncol; 1987 Dec; 14(4):425-34. PubMed ID: 3321447
[No Abstract] [Full Text] [Related]
12. [Personal experience with treatment of acute myeloid leukemia using the DAT combination].
Lukásová M; Sedlácková M; Chudomel V
Cas Lek Cesk; 1990 Oct; 129(43):1352-6. PubMed ID: 2249232
[TBL] [Abstract][Full Text] [Related]
13. On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group.
Löwenberg B; Zittoun R; Kerkhofs H; Jehn U; Abels J; Debusscher L; Cauchie C; Peetermans M; Solbu G; Suciu S
J Clin Oncol; 1989 Sep; 7(9):1268-74. PubMed ID: 2475589
[TBL] [Abstract][Full Text] [Related]
14. [Pathomorphosis of acute leukemia].
Popov VM
Sov Med; 1991; (9):15-8. PubMed ID: 1724709
[TBL] [Abstract][Full Text] [Related]
15. Dysmegakaryopoiesis resembling acute megakaryoblastic leukemia in treated acute myeloid leukemia.
Rosenthal NS; Farhi DC
Am J Clin Pathol; 1991 Apr; 95(4):556-60. PubMed ID: 2014782
[TBL] [Abstract][Full Text] [Related]
16. Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion molecules.
Arienti F; Gambacorti-Passerini C; Borin L; Rivoltini L; Orazi A; Pogliani EM; Corneo G; Parmiani G
Ann Oncol; 1992 Feb; 3(2):155-62. PubMed ID: 1606087
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of 13-cis-retinoic acid in pediatric patients with acute nonlymphocytic leukemia--a Pediatric Oncology Group study.
Bell BA; Findley HW; Krischer J; Whitehead VM; Holbrook T; Haggard ME; Konrad PN; Hensley M; Ragab AH
J Immunother (1991); 1991 Apr; 10(2):77-83. PubMed ID: 2043596
[TBL] [Abstract][Full Text] [Related]
18. [Our experiences in the treatment of acute leukemias].
Jelić S; Dragović M; Vidaković B; Plecas V
Bilt Hematol Transfuz; 1976; 4(1-2):87-95. PubMed ID: 1066129
[TBL] [Abstract][Full Text] [Related]
19. Impetiginous lesions in recurrent AML.
Morris DJ; Lyman GH; Muus C
Hosp Pract (Off Ed); 1989 Mar; 24(3A):153-6. PubMed ID: 2494201
[No Abstract] [Full Text] [Related]
20. Chemotherapy of acute myeloid leukemia of 35- to 60-year-old patients.
Fleischer J; Reinhardt U; Wolf H; Helbig W; Anger G; Grau I; Schott G; Konrad H; Klinkenstein C; Steglich J
Haematol Blood Transfus; 1990; 33():392-4. PubMed ID: 2323648
[No Abstract] [Full Text] [Related]
[Next] [New Search]
